1. Home
  2. CNTB vs DIT Comparison

CNTB vs DIT Comparison

Compare CNTB & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • DIT
  • Stock Information
  • Founded
  • CNTB 2012
  • DIT 1981
  • Country
  • CNTB United States
  • DIT United States
  • Employees
  • CNTB N/A
  • DIT N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • DIT Food Distributors
  • Sector
  • CNTB Health Care
  • DIT Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • DIT Nasdaq
  • Market Cap
  • CNTB 90.3M
  • DIT 75.2M
  • IPO Year
  • CNTB 2021
  • DIT 1995
  • Fundamental
  • Price
  • CNTB N/A
  • DIT N/A
  • Analyst Decision
  • CNTB Strong Buy
  • DIT
  • Analyst Count
  • CNTB 2
  • DIT 0
  • Target Price
  • CNTB $7.50
  • DIT N/A
  • AVG Volume (30 Days)
  • CNTB 88.0K
  • DIT 423.0
  • Earning Date
  • CNTB 11-13-2025
  • DIT 11-07-2025
  • Dividend Yield
  • CNTB N/A
  • DIT 0.85%
  • EPS Growth
  • CNTB N/A
  • DIT N/A
  • EPS
  • CNTB N/A
  • DIT 2.14
  • Revenue
  • CNTB $1,965,000.00
  • DIT $2,251,684,195.00
  • Revenue This Year
  • CNTB N/A
  • DIT N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • DIT N/A
  • P/E Ratio
  • CNTB N/A
  • DIT $54.69
  • Revenue Growth
  • CNTB N/A
  • DIT 7.64
  • 52 Week Low
  • CNTB $1.23
  • DIT $94.92
  • 52 Week High
  • CNTB $2.20
  • DIT $163.75
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 58.99
  • DIT N/A
  • Support Level
  • CNTB $1.36
  • DIT N/A
  • Resistance Level
  • CNTB $1.88
  • DIT N/A
  • Average True Range (ATR)
  • CNTB 0.15
  • DIT 0.00
  • MACD
  • CNTB 0.04
  • DIT 0.00
  • Stochastic Oscillator
  • CNTB 99.48
  • DIT 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: